SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001839882-22-022701
Filing Date
2022-10-03
Accepted
2022-10-03 16:51:42
Documents
2
Period of Report
2022-09-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 booth-form3_093022.html 3  
1 FORM 3 booth-form3_093022.xml 3 1624
2 LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS ex-24.htm EX-24 10419
  Complete submission text file 0001839882-22-022701.txt   13631
Mailing Address C/O PHARMACYCLICS, INC. 995 EAST ARQUES AVENUE SUNNYVALE CA 94085
Business Address
Booth Robert F. (Reporting) CIK: 0001507567 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36866 | Film No.: 221288142

Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations